|
Apr 3
|
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
|
|
Apr 1
|
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
|
|
Mar 14
|
Inspira Technologies (IINN) Releases Favorable Data on VORTX
|
|
Mar 12
|
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
|
|
Jan 9
|
Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity
|
|
Dec 18
|
Inspira Technologies to Participate in J.P. Morgan Healthcare Conference
|
|
Nov 30
|
Inspira (IINN) Expands in Life Support Space With New Deal
|
|
Nov 29
|
Inspira Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
|
|
Nov 16
|
Inspira™ Technologies Reports Third Quarter 2023 Financial Results
|
|
Nov 6
|
Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology
|
|
Aug 10
|
Inspira™ Technologies Reports Second Quarter 2023 Financial Results
|
|
Aug 9
|
INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.
|
|
Apr 24
|
Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV
|
|
Apr 24
|
Inspira(TM) Technologies to Present at the Planet MicroCap Showcase 2023 on Wednesday, April 26, 2023 in Las Vegas
|